跳至主要内容
临床试验/NCT00551681
NCT00551681已完成不适用

Effects of Left Ventricular Pacing Optimilization on Cardiac Perfusion, Contractile Force, and Clinical Performance in Patients With Ventricular Dysfunction and Heart Failure

R&D Cardiologie1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2007年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
52
试验地点
1
主要终点
Degree of change in cardiac perfusion following epicardial LV lead placement, compared to transvenous LV lead placement

研究概览

简要总结

To compare a surgical approach of LV lead placement for BIV pacing with the conventional transvenous approach by assessment of differences on the effects on cardiac perfusion and relate this to the clinical cardiac function.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Heart failure NYHA III or IV
  • •QRS duration >120msec or, when paced > 200msec on 12-lead ECG
  • •LBBB on ecg
  • •LV ejection fraction 35% or less
  • •LV dyssynchony on echocardiography

排除标准

  • •Severe (drug refractory) heart failure with short (<6 months) life expectancy.
  • •Permanent or persistent atrial fibrillation
  • •Other indications for cardiac surgery within 6 months
  • •Life expectancy less than one year due to other conditions
  • •Major contra-indication for general anaesthesia
  • •Participation in another study
  • •Pregnancy or the desire to become pregnant during the follow up of the study.

研究组 & 干预措施

1

Active Comparator

Epicardial left ventricular lead placement

干预措施: biventricular pacemaker with epicardial left ventricular lead (Device)

2

Active Comparator

transvenous left ventricular lead

干预措施: transvenous left ventricular lead placement (Device)

结局指标

主要结局

Degree of change in cardiac perfusion following epicardial LV lead placement, compared to transvenous LV lead placement

时间窗: 6 months

次要结局

  • Resynchronization of the LV, measured with TDI, 2D- and 3D-echocardiography, in patients with epicardial LV lead placement, compared to transvenous LV lead placement(6 months)

研究者

发起方
R&D Cardiologie
申办方类型
Other
责任方
Principal Investigator
主要研究者

Vincent van Dijk

MD

R&D Cardiologie

研究点 (1)

Loading locations...

相似试验